| 1 (61) | Samsung Corp * | MUL |  |
| 2 (72) | Ionis Pharmaceuticals | USA |  |
| 3 (82) | Siemens AG, Germany | DEU |  |
| 4 (103) | AstraZeneca, Sweden | SWE |  |
| 5 (106) | Siemens * | MUL |  |
| 6 (123) | Siemens AG, USA | USA |  |
| 7 (142) | Sanofi, France | FRA |  |
| 8 (154) | Regeneron Pharmaceuticals Inc | USA |  |
| 9 (158) | Siemens Healthineers, USA | USA |  |
| 10 (162) | Janssen | MUL |  |
| 11 (164) | AstraZeneca * | MUL |  |
| 12 (167) | Sanofi, United States | USA |  |
| 13 (188) | Johnson & Johnson * | MUL |  |
| 14 (200) | Sanofi * | MUL |  |
| 15 (202) | Janssen Biotech Inc | USA |  |
| 16 (206) | Robert Bosch * | MUL |  |
| 17 (214) | Merck & Co Inc, United States | USA |  |
| 18 (237) | Bosch, Germany | DEU |  |
| 19 (244) | GlaxoSmithKline * | MUL |  |
| 20 (258) | Merck * | MUL |  |
| 21 (263) | Siemens Healthineers, Germany | DEU |  |
| 22 (280) | Novartis * | MUL |  |
| 23 (286) | Abbott Laboratories * | MUL |  |
| 24 (288) | Bristol-Myers Squibb Company, United States | USA |  |
| 25 (365) | Bristol-Myers Squibb Company * | MUL |  |
| 26 (371) | Boehringer Ingelheim GmbH Germany | DEU |  |
| 27 (384) | Boehringer Ingelheim * | MUL |  |
| 28 (394) | Novartis Pharmaceuticals, United States | USA |  |
| 29 (434) | Bayer * | MUL |  |
| 30 (479) | Koninklijke Philips NV * | MUL |  |
| 31 (480) | Ormat Technologies, United States | USA |  |
| 31 (480) | Ormat Technologies Inc * | MUL |  |
| 33 (498) | Hoffmann-La Roche Ltd, Switzerland | CHE |  |
| 34 (523) | Bayer AG, Germany | DEU |  |
| 35 (526) | Novo Nordisk * | MUL |  |
| 36 (540) | Novo Nordisk A/S | DNK |  |
| 37 (548) | Novartis, Switzerland | CHE |  |
| 38 (566) | Amgen, USA | USA |  |
| 39 (571) | Amgen * | MUL |  |
| 40 (588) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA |  |
| 41 (592) | Mitsubishi Corp * | MUL |  |
| 42 (594) | Boston Scientific Corp * | MUL |  |
| 43 (596) | Boston Scientific Corp, USA | USA |  |
| 44 (632) | F Hoffmann-La Roche * | MUL |  |
| 45 (662) | AstraZeneca, United Kingdom | GBR |  |
| 46 (720) | Medtronic * | MUL |  |
| 47 (730) | Medtronic Inc, USA | USA |  |
| 48 (764) | Hoffmann-La Roche Ltd, United States | USA |  |
| 49 (816) | Genentech Inc | USA |  |
| 50 (854) | AstraZeneca, United States | USA |  |
| 51 (869) | Pfizer * | MUL |  |
| 52 (888) | Pfizer Inc, United States | USA |  |
| 53 (1208) | Boehringer Ingelheim, USA | USA |  |
| 54 (1224) | Hitachi * | MUL |  |
| 55 (1296) | General Electric Company * | MUL |  |
| 56 (1329) | Daiichi Sankyo Co., Ltd. * | MUL |  |
| 57 (1424) | Daiichi Sankyo Co., Ltd. Japan | JPN |  |
| 58 (1672) | GE Healthcare, United States | USA |  |
| 59 (1758) | GE Healthcare | MUL |  |
| 60 (1799) | Manipal Global Education Group * | MUL |  |
| 61 (1839) | Anima Holding SA * | BRA |  |
| 62 (1844) | Hitachi Ltd, Japan | JPN |  |
|